Sanofi SA vs Wheaton Precious Metals Corp — how do they compare? Sanofi SA trades at $40.07 (market cap $95.18B), while Wheaton Precious Metals Corp trades at $138.65 (market cap $61.17B). The key difference: Sanofi SA is the larger of the two by market cap, and Sanofi SA pays the higher dividend (6.01%). Which is the better fit depends on your goals — on Pluang, investors hold Sanofi SA for 94 Days and Wheaton Precious Metals Corp for 66 Days on average.
| SNY | WPM | |
|---|---|---|
Market Cap | $95.18B | $61.17B |
Volume | 2,995,646 | 1,092,361 |
Sector | Health | Basic Materials |
52-Week High | $52.34 | $165.72 |
52-Week Low | $39.51 | $94.37 |
Typical Hold Time | 94 Days | 66 Days |
Enterprise Value | $114.48B | $63.05B |
Dividend Yield | 6.01% | 0.58% |
Signals from Pluang's Aura AI — not financial advice
Sanofi (SNY) trades at $40.07, down 0.32% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.21 exceeding the $1.10 estimate. Revenue for 2025 reached $46.72 billion, with a net income margin of 16.72%. Recent news highlights a significant $8 billion immunology alliance expansion with Regeneron, signaling strategic growth initiatives.
The outlook is mixed; solid profitability and a strategic partnership provide upside potential, but a projected net income decline to $4.0 billion in 2026 and bearish technical indicators pose risks. Analyst sentiment is cautiously optimistic with a 44% buy rating, though investors should monitor execution of new collaborations and patent expiration impacts.
WPM trades at $138.65, up 3.71% today, with a bearish technical signal from moving averages but strong fundamental performance. The company reported record 2025 revenue of $2.31B and net income of $1.47B, with earnings beating estimates in recent quarters. Analyst consensus is strongly bullish with an 80% buy rating and a $164.80 price target. Recent news highlights production growth targets of 1.2M ounces by 2030 and a fully funded pipeline.
The outlook for WPM is positive given robust earnings growth, high profitability margins, and strategic expansion plans. Key risks include execution of growth targets, commodity price volatility, and interest rate sensitivity. The stock offers upside to consensus targets but faces technical resistance near current levels.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →